首页> 美国卫生研究院文献>Pathogens >Preparation of Poly (dl-Lactide-co-Glycolide) Nanoparticles Encapsulated with Periglaucine A and Betulinic Acid for In Vitro Anti-Acanthamoeba and Cytotoxicity Activities
【2h】

Preparation of Poly (dl-Lactide-co-Glycolide) Nanoparticles Encapsulated with Periglaucine A and Betulinic Acid for In Vitro Anti-Acanthamoeba and Cytotoxicity Activities

机译:佩格劳辛A和贝特林酸包裹的聚(dl-丙交酯-乙交酯)纳米粒子的制备及其体外抗-虫和细胞毒性作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Poly (dl-lactide-co-glycolide) (PLGA) microspheres were synthesized as delivery system for the natural anti-parasitic compounds, Periglaucine A (PGA) and Betulinic acid (BA). Periglaucine A and Betulinic acid were encapsulated in PLGA nanoparticles by single emulsion method with an average particle size of approximately 100–500 nm. Periglaucine A and Betulinic acid encapsulation efficiency was observed to be 90% and 35% respectively. Anti-Acanthamoeba property of Periglaucine A and Betulinic acid remained intact after encapsulation. PGA-PLGA and BA-PLGA nanoparticles demonstrated inhibition in viability of Acanthamoeba triangularis trophozoites by 74.9%, 59.9%, 49.9% and 71.2%, 52.2%, 88% respectively at concentration of 100 µg/mL, 50 µg/mL and 25 µg/mL. Cytotoxicity of PGA-PLGA and BA-PLGA nanoparticles has been evaluated against lung epithelial cell line and showed dose dependent cytotoxicity value of IC50 2 µg/mL and 20 µg/mL respectively. Futher, increased viability was observed in lung epithelial cell line in higher doses of synthesized polymeric nanoparticles. Results indicate that poly (dl-lactide-co-glycolide) (PLGA) nanoparticles could be exploratory delivery systems for natural products to improve their therapeutic efficacy.
机译:合成了聚(dl-丙交酯-共-乙交酯)(PLGA)微球,作为天然抗寄生虫化合物Periglaucine A(PGA)和桦木酸(BA)的递送系统。 Periglaucine A和贝妥林酸通过单乳液法封装在PLGA纳米颗粒中,平均粒径约为100–500 nm。观察到Periglaucine A和贝妥林酸的包封效率分别为90%和35%。包封后,Periglaucine A和贝妥林酸的抗棘阿米巴性质保持不变。 PGA-PLGA和BA-PLGA纳米颗粒在100μg/ mL,50μg/ mL和25μg的浓度下分别显示出对棘形棘阿米巴滋养体活力的抑制分别为74.9%,59.9%,49.9%和71.2%,52.2%,88%。 /毫升已评估了PGA-PLGA和BA-PLGA纳米颗粒对肺上皮细胞系的细胞毒性,并显示了剂量依赖性的细胞毒性值,IC50分别为2 µg / mL和20 µg / mL。此外,在较高剂量的合成聚合物纳米颗粒中,在肺上皮细胞系中观察到了增加的生存力。结果表明,聚(dl-丙交酯-共-乙交酯)(PLGA)纳米颗粒可以作为天然产品的探索性递送系统,以提高其治疗功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号